06.02.2014 • NewsDede WillamsSaudi ArabiaSolar Power

Saudi Arabia to Build $6.4 million Solar Panels Unit

Saudi Arabia has signed an agreement with SunEdison of Belmont, California, to explore building a $6.4 billion solar panel plant at Wa'ad Al Shammal, in the northern part of the kingdom.

According to U.S. press reports, the facility would produce enough photovoltaic solar modules annually to generate three gigawatts of electricity annually, equivalent to the output of three nuclear reactors.
SunEdison CEO Ahmad Chatila said in a statement that the project will support the expected substantial growth in solar photovoltaics within the kingdom and the region. Government investment agencies are reportedly footing the bill.

With oil resources no longer expected to be a ticket to long-term wealth, Saudi Arabia and its companies are increasingly seeking other opportunities for growth. Sabic CEO Mohammed Al Mady last year said his company was interested in becoming involved in a U.S. shale gas project.

The Saudi government also has set ambitious targets for renewable energy. About a third of the country's energy output is targeted to come from renewables by 2032. The government of the United Arab Emirates is building an entire community, Masdar City, planned to run solely on renewable energy.
Energy consultants noted that while Saudi Arabia has the right climatic conditions for solar power, it has some way to go before developing the market.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.